• huahana-cl1s11

ʻO SARS-CoV-2 Antigen Assay Kit

ʻO ka wehewehe pōkole:


  • Kumukuai FOB:US $0.8 - 1 / ʻāpana
  • Min.Kauoha Nui:10000 ʻāpana/ ʻāpana
  • Hiki ke hoolako:10000000 ʻāpana / ʻāpana i kēlā me kēia mahina
  • :
  • Huahana Huahana

    Huahana Huahana

    SARS-CoV-2 Antigen Assay Kit

    Immunochromatography Method) Product Manual

     

    PRODUCT NAMEʻO SARS-CoV-2 Antigen Assay KitKe ʻano Immunochromatography)

    PACKAGING SPECIFICATIONS1 Ho'āʻo / Kit ,25 Hōʻoia / Kit, 100 Ho'āʻo / Kit

    ABSKAUKA

    Aia nā coronaviruses hou i ka genus β. ʻO COVID-19 kahi maʻi maʻi ʻeha hanu. Hiki ke maʻalahi nā kānaka. I kēia manawa, ʻo nā maʻi i loaʻa i ka coronavirus novel ke kumu nui o ka maʻi; Hiki i nā kānaka maʻi asymptomatic ke lilo i kumu maʻi. Ma muli o ka noiʻi epidemiological o kēia manawa, ʻo ka manawa incubation he 1 a 14 mau lā, ʻo ka hapa nui he 3 a 7 mau lā. ʻO nā hōʻike nui e pili ana i ke kuni, ka luhi a me ka ʻū maloʻo. Loaʻa ka nasal congestion, runny ihu, ʻeha ʻāʻī, myalgia a me ka diarrhea i kekahi mau hihia.

    EXPECTED USAGE

    Hoʻohana ʻia kēia kime e ʻike pono ai i ka antigen coronaviruses (SARS-CoV-2) i loko o nā ʻāʻī ʻāʻī o ke kanaka, nā ʻāʻī waha, nā kohu oropharyngeal hope, ka sputum a me nā mea hoʻohālike.

    He kūpono wale ia no ka ʻoihana in vitro diagnostic, ʻaʻole no ka hoʻohana pilikino.

    Hoʻohana wale ʻia kēia huahana i nā laboratories clinical a i ʻole ka hoʻāʻo koke ʻana e nā limahana lapaʻau. ʻAʻole hiki ke hoʻohana ʻia no ka hoʻāʻo home.

    ʻAʻole hiki ke hoʻohana ʻia i kumu no ka maʻi a me ka wehe ʻana i ka maʻi pneumonia i hoʻokumu ʻia e nā maʻi coronaviruses (SARS-CoV-2). ʻAʻole kūpono ia no ka nānā ʻana e ka lehulehu.

    Pono ka hopena ho'āʻo maikaʻi i ka hōʻoia hou ʻana, a ʻaʻole hiki i ka hopena hoʻāʻo maikaʻi ʻole ke kāpae i ka hiki ke loaʻa ka maʻi.

    ʻO ka pahu a me nā hopena hoʻāʻo no ka hōʻike lapaʻau wale nō. Manaʻo ʻia e hui pū ʻia nā hōʻike lapaʻau o ka mea maʻi a me nā hoʻokolohua ʻē aʻe no ka loiloi piha ʻana o ke kūlana.

    PRINCIPLES OF THE PROCEDURE

    Hoʻohana kēia huahana i ka ʻenehana immunochromatography gula colloidal, kāpīpī i ke gula colloidal i kapa ʻia ʻo SARS-CoV-2 mono-clonal antibody 1 ma ka pā gula. Hoʻopili ʻia ka anti-mouse IgG antibody e like me ka laina mana maikaʻi (laina C). Ke hoʻohui ʻia ka nui kūpono o ka hāpana e hoʻāʻo ʻia i ka lua hāpana o ke kāleka hoʻāʻo, e neʻe ka hāpana ma ke kāleka hōʻike ma lalo o ka hana capillary. Inā loaʻa i ka laʻana kahi antigen SARS-CoV-2, e hoʻopaʻa ʻia ka antigen me ke gula colloidal i kapa ʻia ʻo SARS-CoV-2 monoclonal antibody 1, a ʻo ka paʻakikī paʻakikī e hana i kahi paʻakikī me ka SARS-CoV-2 monoclonal antibody 2 i uhi ʻia. ʻO ka laina T, e hōʻike ana i kahi laina T poni-ulaʻula, e hōʻike ana he maikaʻi ka antigen SARS-CoV-2. Inā ʻaʻole hōʻike ka laina hoʻāʻo T i ke kala a hōʻike i kahi hopena maikaʻi ʻole, ʻo ia ka mea ʻaʻole i loaʻa i ka laʻana ka antigen SARS-CoV-2. Aia i loko o ke kāleka ho'āʻo ka laina mana maikaʻi C, me ka nānā ʻole inā aia kahi laina hoʻāʻo, pono ke ʻike ʻia ka laina mana maikaʻi ʻulaʻula-ʻulaʻula C. Inā ʻaʻole ʻike ʻia ka laina hoʻokele maikaʻi C, hōʻike ia he hewa ʻole ka hopena hōʻike, a pono e hoʻāʻo hou ʻia kēia hāpana.

    MAIN COMPONENTS

    1. Kāleka hoʻāʻo : Aia ke kāleka hoʻāʻo me kahi kāleka plastik a me kahi pahu hoʻāʻo. Hana ʻia ka pahu hoʻāʻo me ka membrane nitrocellulose (ua uhi ʻia ka wahi ʻike me ka SARS-CoV-2 monoclonal antibody 2, ua uhi ʻia ka wahi hoʻomalu maikaʻi me ke kao antimouse IgG antibody), a me ka pā gula (i kāpī ʻia me ke gula colloidal i kapa ʻia ʻo SARS-CoV- 2 monoclonal antibody 1), pad sample, pepa absorbent, a me ka papa PVC.

    2. Laʻana hoʻoheheʻe ʻia: ʻO ka hopena Buffer i loaʻa ka phosphate e pili ana i nā kikoʻī o ka pahu (pH6.5-8.0).

    3. Laʻana hoʻoheheʻe paipu.

    4. Sterile swab, hamo, ipu.

    5. Manual.

    'Ōlelo Aʻo: ʻAʻole hiki ke hoʻohana ʻia nā ʻāpana o nā pūʻulu ʻokoʻa.

     

     

    Cat. No. YXN-SARS-AT-01 YXN-SARS-AT-25 YXN-SARS-AT-100
    Package Specifications 1 test/kit 25 tests/kit 100 tests/kit
    Laʻana hoʻoheheʻe ʻia 1mL/'ōmole 5mL/'ōmole * 6 mau ʻōmole 5mL/ ʻōmole * 24 mau ʻōmole
    Pupu hoʻoheheʻe laʻana 1 ho'āʻo * 1 pūʻolo ≥25 ho'āʻo* 1 pūʻolo ≥25 ho'āʻo* 4 pūʻolo
    manual 1 apana 1 apana 1 apana

     

    STORAGE A ME EXPIIOLEION

    ʻO ka manawa kūpono he 18 mau mahina inā mālama ʻia kēia huahana ma kahi o 2 ℃-30 ℃.

    Pono e hoʻohana ʻia ka huahana i loko o 15 mau minuke ke wehe ʻia ka ʻeke pepa. Hōʻike ʻia ka lā hana a me ka lā pau ma ka lepili.

    SAMPLE REQUIREMENTS

    1. E pili ana i ke kanaka nasal throat swabs, oral throat swabs, posterior oropharyngeal saliva, sputum and stool samples.

    2. ʻOhi laʻana:

    ( 1) Ohi huna ihu: I ka ohi ana i na huna huna, e hookomo i ka pulupulu sterile i loko o kahi o ka huna nui i loko o ka ihu, huli malie a pahu i ka swab i loko o ka nasal cavity a hiki i ka turbinate i ālaiia, a hoohuli i ka swab ekolu. manawa kū i ka paia o ka ihu

     

    1

     

    a lawe i ka pulupulu.

    (2) ʻOhi huna ʻāʻī: E hoʻokomo i kahi swab sterile i loko o ka ʻāʻī mai ka waha, e kau ana ma ka paia o ka ʻāʻī a me ka ʻāpana ʻulaʻula o ka palate tonsils, holoi i nā tonsils pharyngeal bilateral a me ka paia pharyngeal hope me ka ikaika haʻahaʻa, e pale i ka hoʻopā ʻana i ke alelo. a lawe i ka pulupulu.

    (3) Kohu oropharyngeal hope: Hana i ka hoʻomaʻemaʻe lima me ke kopa a me ka wai. Wehe i ka ipu. E hana i ka leo Kruuua mai ka puʻu e hoʻomaʻemaʻe i ka ʻāʻī mai ka ʻāʻī hohonu, a laila e kuha i ka kohu (ma kahi o 2 ml) i loko o ka ipu. E pale i ka hoʻohaumia ʻana o ke kohu o ka ʻili o waho o ka ipu. ʻO ka manawa kūpono o ka hōʻiliʻili ʻana: Ma hope o ke ala ʻana a ma mua o ka palaki ʻana i nā niho, ʻai a inu paha.

    3. E hana koke i ka hāpana me ka hāpana unuhi i hāʻawi ʻia i loko o ka pahu ma hope o ka hōʻiliʻili ʻana o ka hāpana. Inā ʻaʻole hiki ke hana koke ʻia, pono e mālama ʻia ka hāpana i loko o kahi pahu plastik maloʻo, sterilized a hoʻopaʻa paʻa ʻia. Hiki ke mālama ʻia ma 2 ℃ -8 ℃ no 8 mau hola, a hiki ke mālama ʻia no ka manawa lōʻihi ma -70 ℃.

    4. ʻAʻole hiki ke hoʻohana ʻia nā laʻana i hoʻohaumia nui ʻia e nā koena meaʻai waha no ka hoʻāʻo ʻana i kēia huahana. ʻAʻole ʻōlelo ʻia nā laʻana i hōʻiliʻili ʻia mai nā swabs i ʻoi aku ka viscous a i ʻole agglomerated no ka hoʻāʻo ʻana i kēia huahana. Inā haumia nā swabs me ka nui o ke koko, ʻaʻole ʻōlelo ʻia no ka hoʻāʻo ʻana. ʻAʻole ʻōlelo ʻia e hoʻohana i nā laʻana i hoʻopaʻa ʻia me ka hāʻina hoʻoheheʻe ʻana i hāʻawi ʻole ʻia i loko o kēia pahu no ka hoʻāʻo ʻana i kēia huahana.

    TESTING METHOD

    E ʻoluʻolu e heluhelu pono i ka manual ma mua o ka hoʻāʻo ʻana. E ʻoluʻolu e hoʻihoʻi i nā reagents a pau i ka wela lumi ma mua o ka hoʻāʻo. Pono e hana i ka ho'āʻo ma ka lumi wela.

    Nā ʻanuʻu hoʻāʻo:

    1. Laʻana unuhi:

    ( 1) Kohu oropharyngeal hope, laʻana sputum: E hoʻohui i ka 200ul sample extraction solution (e pili ana i 6 kulu) i loko o ka pahu hoʻoheheʻe hāpana a hoʻololi i kahi 200μL o ka saliva hou a i ʻole ka sputum mai ka pahu i loko o ka Sample Extraction Tube a lulu a hui piha.

    (2) Ka Laʻana Pahu: E hoʻohui i 200ul sample extraction solution (e pili ana i 6 kulu) i loko o ka pahu hoʻoheheʻe hāpana, e hoʻohana i ke koʻokoʻo laʻana e kiʻi ma kahi o 30mg o nā laʻana stool hou (E like me ka nui o ke poʻo hoʻokūkū). E hoʻokomo i ke koʻokoʻo laʻana i loko o ka Sample Extraction Tube a hoʻoluliluli a hui pū ʻia a hiki i ka pau ʻana o ka pahu.

    3 E hoʻokomo i ka swab i hōʻiliʻili ʻia i loko o ka hāpana i loko o ka hāpana hoʻoheheʻe ʻia, a e hoʻohuli iā ia kokoke i ka paia o loko o ka paipu hoʻāʻo ma kahi o 10 mau manawa e hoʻoheheʻe ʻia ka hāpana i ka hopena e like me ka hiki. E kaomi i ke poʻo o ka pulupulu ma ka paia o loko o ka paipu unuhi e mālama i ka wai i loko o ka paipu e like me ka hiki, e wehe a hoʻolei i ka swab. E uhi i ka poʻi.

    2. Nā kaʻina hana ʻike:

    (1) Ma hope o ka hoʻi ʻana o ke kāleka hoʻāʻo i ka wela lumi, e wehe i ka ʻeke alumini alumini a lawe i waho i ke kāleka hoʻāʻo a kau ʻia ma ka pākaukau.

    (2) E hoʻohui i 65ul (e pili ana i 2 kulu) o ka mea hoʻoheheʻe i hana ʻia a i ʻole e hoʻohui pololei i 65ul (e pili ana i 2 kulu) o ka hopena laʻana virus i hana ʻia i ka lua hāpana o ka kāleka hōʻike.

    (3) Heluhelu i ka hopena i hōʻike ʻia i loko o 15-30 mau minuke, a ʻaʻole kūpono nā hualoaʻa ma hope o 30 mau minuke.

    IOLELO HOOLAHAION OF TEST RESULTS

     

     

    ★ Hōʻike ka laina hoʻāʻo (T) a me ka laina hoʻokele (C) i nā ʻāpana kala e like me ka hōʻike ʻana o ke kiʻi ma ke ʻano pololei, e hōʻike ana he maikaʻi ka antigen SARS-CoV-2.
    ★NEGATIVE: Inā hoʻomohala wale ka laina hoʻokele maikaʻi C i ke kala a ʻaʻole hoʻomohala ka laina hoʻāʻo (T) i ke kala, ʻaʻole ʻike ʻia ka antigen SARSCoV-2 a maikaʻi ʻole ka hopena, e like me ka hōʻike ʻana o ke kiʻi he pololei.
    ★INVALID: ʻAʻole ʻike ʻia ka pūʻulu kala ma ka laina hoʻomalu maikaʻi (C), a ua manaʻo ʻia he hopena kūpono ʻole inā ʻike ʻia ka laina ʻike (T) i ka pūʻulu kala a ʻaʻole paha, e like me ka hōʻike ʻana o ke kiʻi he pololei. ʻAʻole ʻike ʻia ka laina hoʻokele. local distributor.Standard Laboratory Practice (GLP) laboratories e hoʻokō i ka mana maikaʻi e like me nā kaʻina hana hoʻokolohua ma lalo o ke alakaʻi ʻana o nā lula aupuni a kūloko paha.

    2

     

     

     

    LIMITATION OF IKEION METHOD

    1. Hōʻoia hōʻoia

    I mea e loiloi ai i ka hana diagnostic, ua hoʻohana kēia haʻawina i nā hōʻailona COVID-19-maikaʻi mai 252 mau kānaka a me COVID-19-ʻino mai nā kānaka 686. Ua hoʻāʻo ʻia a hōʻoia ʻia kēia mau hiʻohiʻona e ke ʻano RT-PCR. ʻO nā hopena penei:

    a) ʻIke: 95.24%(240/252), 95%CI(91.83%, 97.52%)

    b) Kūikawā: 99. 13%(680/686), 95%CI(98. 11%, 99.68%)

    2. palena ʻike liʻiliʻi loa:

    Ke ʻoi aku ka nui o ka maʻi maʻi ma mua o 400TCID50/ml, ʻoi aku ka nui o ka ʻike maikaʻi ma mua o 95%. Ke emi ka maʻi maʻi ma lalo o 200TCID50/ml, ʻoi aku ka liʻiliʻi o ka helu ʻike maikaʻi ma mua o 95%, no laila, ʻo ka palena haʻahaʻa loa o kēia huahana he 400TCID50/ml.

    3. Ka pololei:

    Ua hoʻāʻo ʻia ʻekolu mau pūʻulu reagents no ka pololei. Ua hoʻohana ʻia nā ʻāpana like ʻole o nā reagents no ka hoʻāʻo ʻana i ka hāpana like ʻole he 10 mau manawa i ka holomua, a ʻo nā hopena a pau ʻino. Ua hoʻohana ʻia nā ʻāpana like ʻole o nā reagents e hoʻāʻo i ka laʻana maikaʻi like 10 mau manawa i ka holomua, a ua maikaʻi nā hopena.

    4. Ka hopena HOOK:

    Ke hiki i ka 4.0*105TCID50/ml ka maʻiʻo maʻiʻo i loko o ka hāpana e hoʻāʻo ʻia, ʻaʻole hōʻike ka hopena hoʻāʻo i ka hopena HOOK.

    5. Kea-reactivity

    Ua loiloi ʻia ka hoʻololi ʻana o ka pahu. ʻAʻole i hōʻike ʻia nā hopena i ka hoʻoikaika ʻana me kēia ʻano hoʻohālike.

     

     

    ʻAʻole. 'ikamu Conc. ʻAʻole. 'ikamu Conc.
    1 HCOV-HKU1 105TCID50/ml 16 Influenza A H3N2 105TCID50/ml
    2 ʻO Staphylococcus aureus 106TCID50/ml 17 H7N9 105TCID50/ml
    3 ʻO ka hui A streptococci 106TCID50/ml 18 H5N1 105TCID50/ml
    4 Maʻi ʻino 105TCID50/ml 19 ʻO ka maʻi virus Epstein-Barr 105TCID50/ml
    5 ʻO ka maʻi maʻi mumps 105TCID50/ml 20 Enterovirus CA16 105TCID50/ml
    6 ʻO Adenovirus ʻano 3 105TCID50/ml 21 Rhinovirus 105TCID50/ml
    7 Mycoplasmal pneumonia 106TCID50/ml 22 Respiratory syncytial virus 105TCID50/ml
    8 Paraimfluenzavirus, ʻano 2 105TCID50/ml 23 Streptococcus pneumoniae 106TCID50/ml
    9 ʻO ka metapneumovirus kanaka 105TCID50/ml 24 ʻO Candida albicans 106TCID50/ml
    10 ʻO ka coronavirus kanaka OC43 105TCID50/ml 25 Chlamydia pneumoniae 106TCID50/ml
    11 ʻO ka coronavirus kanaka 229E 105TCID50/ml 26 ʻO Bordetella pertussis 106TCID50/ml
    12 ʻO Bordetella parapertusis 106TCID50/ml 27 Pneumocystis jiroveci 106TCID50/ml
    13 ʻO ka maʻi Influenza B Victoria 105TCID50/ml 28 Mycobacterium tubercu losis 106TCID50/ml
    14 ʻO ka maʻi maʻi maʻi B Y 105TCID50/ml 29 Legionella pneumophila 106TCID50/ml
    15 Influenza A H1N1 2009 105TCID50/ml

    6. Na mea keakea

    ʻAʻole e hoʻopilikia ʻia nā hopena hōʻike me ka mea ma ke ʻano aʻe:

     

    ʻAʻole. 'ikamu Conc. ʻAʻole. 'ikamu Conc.
    1 Koko holookoa 4% 9 Mucin 0.50%
    2 Ibuprofen 1mg/ml 10 Huihui Benzoin Gel 1.5mg/ml
    3 ʻo ka tetracycline 3ug/ml 11 Cromolyn glycate 15%
    4 chloramphenicol 3ug/ml 12 Deoxyepinephrine hydro chloride 15%
    5 Erythromycin 3ug/ml 13 Afrin 15%
    6 ʻO Tobramycin 5% 14 Fluticasone propionate spray 15%
    7 Oseltamivir 5mg/ml 15 menthol 15%
    8 Holo ʻo Naphazoline Hydrochlo i ka Nasal Drops 15% 16 ʻO Mupirocin 10mg/ml

    LIMITATION OF IKEION METHOD

    1. Hāʻawi wale ʻia kēia huahana i nā laboratories clinical a i ʻole nā ​​limahana lapaʻau no ka hoʻāʻo koke ʻana, ʻaʻole hiki ke hoʻohana ʻia no ka hoʻāʻo ʻana i ka home.

    2. He mea kūpono wale nō kēia huahana no ka ʻike ʻana i nā mea huna o ka ihu kanaka a i ʻole ka puʻu. ʻIke ia i ka maʻiʻo maʻiʻo i loko o ka laʻana unuhi,

     

    3

     

    me ka nānā ʻole inā he maʻi maʻi. No laila, ʻaʻole hiki ke hoʻopili ʻia nā hopena hoʻāʻo o kēia huahana a me nā hopena moʻomeheu virus o ka laʻana like.

    3. Pono e ho'iho'i 'ia ke kāleka ho'ā'o a me ka hāpana unuhi o kēia huahana i ka mahana wela ma mua o ka ho'ohana 'ana. Hiki i ka wela kūpono ke kumu i ka hopena ho'āʻo ʻino.

    4. I ka wā o ka hoʻāʻo ʻana, ʻaʻole like nā hopena hōʻike i nā hopena lapaʻau ma muli o ka lawa ʻole o ka hōʻiliʻili laʻana o nā swabs sterile a i ʻole ka hōʻiliʻili kūpono ʻole a me ka hana unuhi ʻana.

    5. I ka wā o ka hoʻohana ʻana i kēia huahana, pono ʻoe e hahai pono i nā pae hana o ka manual. Hiki i nā hana hana kūpono ʻole a me nā kūlana kaiapuni ke kumu i nā hopena hōʻike ʻokoʻa.

    6. Pono e hoʻololi ʻia ka swab ma kahi o 10 mau manawa ma ka paia o loko o ka paipu hoʻāʻo i loaʻa ka hāpana hoʻoheheʻe. ʻO ka liʻiliʻi a i ʻole ka nui o nā hoʻololi ʻana ke kumu i nā hopena hōʻike ʻokoʻa.

    7. ʻAʻole hiki i ka hopena maikaʻi o kēia huahana ke kāpae i ka hiki ke loaʻa nā pathogens ʻē aʻe.

    8. ʻAʻole hiki i ka hopena hoʻāʻo maikaʻi o kēia huahana ke hoʻokaʻawale ma waena o SARS-CoV a me SARS-CoV-2.

    9. He hopena ho'āʻo maikaʻi ʻole inā ʻaʻole hiki i kēia huahana ke hōʻole i ka hiki ke loaʻa nā pathogens ʻē aʻe.

    10. Manaʻo ʻia nā hopena hōʻike maikaʻi ʻole e hōʻoia me nā reagents ʻike waika nucleic e pale i ka pilikia o ka hoʻāʻo ʻole.

    11. Loaʻa paha nā ʻokoʻa o nā hopena hoʻāʻo ma waena o nā laʻana lāʻau lapaʻau hau a me nā laʻana lāʻau lapaʻau hou i hōʻiliʻili ʻia.

    12. Pono e ho'āʻo koke ʻia ka mea hoʻohālike ma hope o ka hōʻiliʻili ʻana i mea e pale aku ai i nā hopena hoʻokolohua like ʻole ma hope o ka waiho lōʻihi ʻana.

    13. I ka wā o ka hoʻohana ʻana i kēia huahana, pono ka nui o ka laʻana kūpono, ʻoi aku ka liʻiliʻi a i ʻole ka nui o ka nui o ka laʻana i hiki ke hōʻeha i nā hopena hoʻokolohua. Manaʻo ʻia e hoʻohana i ka pipette me ka nui o ka laʻana no ka hōʻike hoʻohui.

    MALAMAIONS

    1. E ʻoluʻolu e hoʻohālikelike i ka hāpana diluent a me ka kāleka hōʻoia i ka lumi wela (ma luna o 30min) ma mua o ka hoʻāʻo.

    2. Pono e hoʻokō ʻia ka nānā ʻana e like me nā kuhikuhi.

    3. Pono e unuhi ʻia ka hopena i loko o 15-30min, a ʻaʻole kūpono ka hopena i heluhelu ʻia ma hope o 30 min.

    4. Pono e noʻonoʻo ʻia ka laʻana hoʻāʻo e like me kahi mea maʻi maʻi, a pono e hana ʻia ka hana e like me nā kikoʻī hana o ka hale hana maʻi infectious, me nā hana pale a me ka nānā ʻana i ka hana bio-safety.

    5. Aia kēia huahana i nā mea holoholona. ʻOiai ʻaʻole ia e lele, pono e mālama ʻia me ka akahele i ka wā e lawelawe ai i nā kumu kumu o ka maʻi. Pono nā mea hoʻohana e hana i nā hana palekana e hōʻoia i ka palekana o lākou iho a me nā poʻe ʻē aʻe.

    6. Hoʻohana ʻia nā kāleka hoʻāʻo i hoʻohana ʻia, nā mea hoʻohālike, a me nā mea ʻē aʻe e like me nā ʻōpala bio-medical ma hope o ka hoʻāʻo ʻana, a holoi i kou mau lima i ka manawa.

    7. Ina ua kahe ka la'ana o keia huahana i ka ili a me ka maka, e holoi koke me ka wai nui, a e imi i ka lapaau ina pono.

    8. Mai hoʻohana i ka pahu me ka poino maopopo, a me ke kāleka hōʻoia me ka pōʻai pōʻino.

    9. He huahana hoʻohana hoʻokahi kēia huahana, e ʻoluʻolu, mai hoʻohana hou, a mai hoʻohana i nā huahana pau.

    10. E pale pono i ka lā a me ka puhi pololei ʻana mai nā pā uila i ka wā e hoʻāʻo ai.

    11. ʻAʻole hiki ke hoʻohana ʻia ka wai kīwī, ka wai i hoʻoheheʻe ʻia a i ʻole ka wai deionized a me nā mea inu e like me nā reagents mana ʻino.

    12. Ma muli o ka ʻokoʻa o nā laʻana, ʻoi aku ka māmā a i ʻole ke kala hina o kekahi mau laina hoʻāʻo. Ma ke ʻano he huahana qualitative, ʻoiai aia kahi hui ma ke kūlana o ka laina T, hiki ke hoʻoholo ʻia he maikaʻi.

    13. Inā maikaʻi ka hoʻāʻo, pono e hoʻohana i kēia kāleka hōʻike e nānā hou i hoʻokahi manawa e pale i nā hanana liʻiliʻi liʻiliʻi.

    14. Aia kahi desiccant i loko o ka ʻeke alumini alumini, mai lawe waha




  • Mua:
  • Aʻe:

  • Nā huahana pili

    • ʻO SARS-CoV-2 Antigen Assay Kit (Immunochromatography Method)

      ʻO SARS-CoV-2 Antigen Assay Kit (Immunochromatogr...

      ʻO SARS-CoV-2 Antigen Assay Kit (Immunochromatography Method) Product Manual 【PRODUCT NAME】SARS-CoV-2 Antigen Assay Kit (Immunochromatography Method) 【PACKAGING SPECIFICATIONS】 1 Test/Kit 【ABSTRACT】 No ka novel coronaviruses genus. ʻO COVID-19 kahi maʻi maʻi ʻeha hanu. Hiki ke maʻalahi nā kānaka. I kēia manawa, ʻo nā mea maʻi i loaʻa i ka novel coronavirus ka mea nui ...

    • ʻO COVID-19 IgM/IgG Mea ʻImi ʻAiʻi

      ʻO COVID-19 IgM/IgG Mea ʻImi ʻAiʻi

      ʻO COVID-19 IgM/IgG Antibody Detection Kit (Colloidal Gold Immunochromatography Method) Product Manual 【PRODUCT NAME】COVID- 19 IgM/IgG Antibody Detection Kit (Colloidal Gold Immunochromatography Method) 【PACKAGING SPECIFICATIONS】Kit1SPECIFICATIONS】 ABSTRACT】 No ka β genus ka coronaviruses hou. ʻO COVID-19 kahi maʻi maʻi ʻeha hanu. Hiki ke maʻalahi nā kānaka. I kēia manawa, ʻo nā mea maʻi i loaʻa i ka coronavirus novel ke kumu nui ...

    • Nucleic Acid Extraction a i ʻole ka pahu hoʻomaʻemaʻe

      Nucleic Acid Extraction a i ʻole ka pahu hoʻomaʻemaʻe

      Nucleic Acid Extraction a i ʻole hui hoʻomaʻemaʻe a mālama ʻia ma -20 ℃. Pono e lawe ʻia ka laʻana me ka 0 ℃ curling. Introduction ʻO ka Nucleic Acid Extraction or Purification Kit (Magnetic Beads Method) ua hoʻolālā ʻia no ka hoʻomaʻemaʻe ʻana i ka RNA a me DNA mai nā wai kino (e like me ka swabs, plasma, serum) me ka hoʻohana ʻana i nā mea hana ʻokiʻoki nucleic acid. Hāʻawi ka ʻenehana magnetic-particle i ka DNA/RNA kiʻekiʻe i kūpono no ...

    • ʻO Coronavirus hou(SARS-Cov-2) pahu ʻimi ʻakika nucleic

      ʻIke ʻia ka ʻakika nucleic hou (SARS-Cov-2) ...

      ʻO Coronavirus hou(SARS-Cov-2) Nucleic Acid Detection Kit (Fluorescent RT-PCR Probe Method) Product Manual 【Product name 】New Coronavirus(SARS-Cov-2) Nucleic Acid Detection Kit (Fluorescent RT-PCR Probe Method) 【Packaging Nā kikoʻī 】 25 Hoʻāʻo / Kit 【Hoʻohana i manaʻo ʻia】 Hoʻohana ʻia kēia kit no ka ʻike qualitative o ka nucleic acid mai ka coronavirus hou i loko o nā swabs nasopharyngeal, oropharyngeal (puʻu) swabs, nasal swabs mua, mid-turbinate swabs, nasal wash and nasal aspirates from indivivi. ...

    E hoʻouna i kāu leka iā mākou:

    E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou